UCB makes major management changes; Bristol Myers’ ADC partner tops list of new CEOs

Iris Loew-Friedrich

→ UCB is shaking up its leadership team “to better align with its commitment to growth and innovation, and to better address the dynamic external landscape of the healthcare industry,” according to a company update on Thursday. The Belgian…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks